Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study).
Luis García de Guadiana RomualdoCarlos Rodríguez RojasDaniel Morell-GarcíaDavid Andaluz-OjedaMaría Dolores Rodríguez MuleroEnrique Rodríguez-BorjaAntonieta Ballesteros-VizosoMaría Dolores CalvoLourdes Albert-BotellaAdela Pozo GiráldezIsabel Llompart-AlabernCristina Bolado JiménezMarta Hernández OlivoLucía Fernández PresaJuan Ortega-PérezMaría José Fora RomeroValerio Campos-RodríguezAndrea Ballester FérrizAlexandra M Guiu-MartíLeyre Pinilla ArribasMaría Galindo MartínezEdwin R Puerto-LaraAna Belen López TarazagaMaría Salomé Ros BraquehaisLeonor Nogales MartínCelia Juez SantamaríaWysalli Trapiello FernándezVirginia Espinilla FernándezAleksandra HavelkaMaría Dolores Albaladejo-OtónPublished in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2021)
Serum calprotectin can be used as an early predictor of severity in COVID-19 patients.